ADAR1 Capital Management’s VYNE Therapeutics VYNE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$147K Buy
2025
Q2
Sell
2025
Q1
$111K Buy
2024
Q4
Sell
2024
Q3
$287K Sell
2024
Q2
$337K Buy
2024
Q1
$338K Buy